AmplifyBio
AmplifyBio is a preclinical contract research organization (CRO) that provides a range of services including toxicology, pharmacology, neuroscience, and advanced therapy manufacturing, alongside discovery services like non-viral gene editing and T cell therapy development.
Preclinical CRO Services
AmplifyBio offers a broad range of preclinical CRO services tailored to meet diverse research needs. Their offerings include general toxicology, preclinical analytics, CRO pathology capabilities, inhalation toxicology, safety pharmacology, oncolytic virotherapy, neuroscience, and pharmacokinetics/toxicokinetics. These services provide essential data and insights to support the development of new therapeutics and advance preclinical research efforts.
Discovery Services
AmplifyBio provides discovery services focused on pioneering non-viral gene editing and T cell therapy development. These services play a crucial role in early-stage scientific exploration, enabling researchers to engineer cells and investigate potential therapeutic targets. Their robust platform leverages advanced technologies to facilitate innovative solutions in gene and cell therapy.
Advanced Therapy Manufacturing
AmplifyBio operates an advanced therapy manufacturing facility known as AMEC. This facility features versatile B- and C-grade suites that can be configured to accommodate any modality and simultaneously produce multiple lots. Their manufacturing capabilities extend to non-viral gene editing and plasmid production, supporting the development and scale-up of advanced therapeutic products.
Immunology and Preclinical Bioanalytic Services
AmplifyBio offers comprehensive immunology services and preclinical bioanalytic services. These support data-driven decision-making during studies, ensuring thorough analysis and interpretation of experimental data. Their expertise in immunology enhances their ability to deliver critical insights that inform the development of new treatments and therapeutic strategies.
Strategic Partnerships
AmplifyBio engages in strategic partnerships to enhance their service offerings. Notably, their partnership with RNAV8 Bio supports mRNA therapeutic developers from sequence design to GMP manufacture. Such collaborations broaden AmplifyBio's capabilities and expand their ability to provide specialized solutions to the biotech and pharmaceutical industries.